HeartRhythm

FEBRUARY 8, 2025

Brugada syndrome (BrS) is associated with an increased risk of ventricular fibrillation (VF), leading to sudden cardiac death. 1 However, variations in the efficacy of these drugs remain unclear, particularly regarding low-dose quinidine.

Sudden Cardiac Death 40

Sudden Cardiac Death Pharmacology Defibrillator 40

HeartRhythm

JANUARY 13, 2024

The increased risk of arrhythmias and sudden cardiac death (SCD) caused by drug-induced QT prolongation has been a prominent safety pharmacology concern for the last 30 years.

Sudden Cardiac Death 71

Sudden Cardiac Death Pharmacology Arrhythmia 71

HeartRhythm

APRIL 30, 2024

Contemporary antiarrhythmic treatment of Timothy syndrome 1 (TS1) is inadequate to prevent sudden cardiac death. Using electroanatomic mapping (EAM) we discovered cardiac activation delay, which creates the milieu for functional reentrant ventricular arrhythmias.

Sudden Cardiac Death 40

Sudden Cardiac Death Pharmacology Electrophysiology Arrhythmia 40

HeartRhythm

AUGUST 27, 2024

Recent reports have spotlighted the potential of pharmacological tests with sodium channel blockers (SCB) in unmasking short-coupled premature ventricular contractions (ScPVCs), most frequently of Purkinje origin, in patients at risk for sudden cardiac death (SCD).1,2

Sudden Cardiac Death 40

Sudden Cardiac Death Pharmacology 40

Journal of Cardiovascular Pharmacology

MAY 7, 2024

Concerns regarding the risk of cardiac arrhythmia and death have been raised, yet the burden of HCQ and CQ-related cardiac toxicities remains unclear.

Sudden Cardiac Death 40

Sudden Cardiac Death Arrhythmia Article Outcomes 40

DAIC

MAY 9, 2024

New HCM Guidelines Updated recommendations in the guideline reflect recent evidence about HCM treatment and management including new forms of pharmacologic management; participation in vigorous recreational activities and competitive sports; and risk stratification for sudden cardiac death (SCD) with an emphasis on pediatric patients.

Cardiomyopathy 52

Cardiomyopathy Pediatrics Quality of Life Sudden Cardiac Death 52

DAIC

JANUARY 23, 2024

21-23 hsCRP is nonspecific inflammatory marker and an acute phase reactant that predicts the likelihood of a heart attack, stroke, peripheral artery disease and sudden cardiac death among healthy individuals with no history of CV disease, and recurrent events and death in patients with known ASCVD.22 2015;45(3):341-350.

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111